A Study of Oxidative Pathways in MS Fatigue

NCT02804594 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Progressive Multiple Sclerosis
Fatigue

Interventions

DRUG: N-acetyl cysteine
DRUG: Placebo

Sponsor

University of California, San Francisco